Back to TRDA
MOORE CAPITAL MANAGEMENT, LP → TRDA
MOORE CAPITAL MANAGEMENT, LP TRDA Position History
Entrada Therapeutics, Inc. • Healthcare
Quarters held
16
Latest value
$667K
Q3 2026
Peak value
$1.8M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $1.5M |
| Q2 2023 | $1.6M |
| Q3 2023 | $1.7M |
| Q4 2023 | $1.6M |
| Q1 2024 | $1.5M |
| Q2 2024 | $1.5M |
| Q3 2024 | $1.7M |
| Q4 2024 | $1.8M |
| Q1 2025 | $949K |
| Q1 2025 | $949K |
| Q2 2025 | $706K |
| Q3 2025 | $609K |
| Q4 2025 | $1.1M |
| Q1 2026 | $1.3M |
| Q2 2026 | $773K |
| Q3 2026 | $667K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $667K | 105.0K | — | — |
| Q2 2026 | $773K | 105.0K | — | — |
| Q1 2026 | $1.3M | 105.0K | — | — |
| Q4 2025 | $1.1M | 105.0K | — | — |
| Q3 2025 | $609K | 105.0K | — | — |
| Q2 2025 | $706K | 105.0K | — | — |
| Q1 2025 | $949K | 105.0K | — | — |
| Q1 2025 | $949K | 105.0K | — | — |
| Q4 2024 | $1.8M | 105.0K | — | — |
| Q3 2024 | $1.7M | 105.0K | — | — |
| Q2 2024 | $1.5M | 105.0K | — | — |
| Q1 2024 | $1.5M | 105.0K | — | — |
| Q4 2023 | $1.6M | 105.0K | — | — |
| Q3 2023 | $1.7M | 105.0K | — | — |
| Q2 2023 | $1.6M | 105.0K | — | — |
| Q1 2023 | $1.5M | 105.0K | — | — |